Brought to you by 
Boston Scientific buys CryoCor for about $17.2mm in cash
24 Apr 2008
Executive Summary
After working together on cryoablation treatments for cardiac arrhythmia over the last year, Boston Scientific has announced it will buy CryoCor (minimally invasive cardio devices) for a total of about $17.2mm ($1.35 in cash for each share, a slight discount).
Deal Industry
- Medical Devices
-
Medical Devices
-
Surgical Equipment & Devices
- Minimally or Less Invasive
-
Surgical Equipment & Devices
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Includes Contract
- Payment Includes Cash
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com